3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Breast Neoplasms
18
Neoplasms
14
Ovarian Neoplasms
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Lymphoma
6
Neoplasm Metastasis
5
Multiple Myeloma
5
Hematologic Neoplasms
5
Prostatic Neoplasms
4
Leukemia
4
Glioblastoma
4
Fatigue
4
Colorectal Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Myelodysplastic Syndromes
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peritoneal Neoplasms
2
Pain
2
Motor Activity
2
Melanoma
2
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Endoscopic Mucosal Resection
1
Diet Therapy
1
Data Collection
1
Cryosurgery
1
Control Groups
1
Colectomy
1
Betaine
1
90Y-octreotide, DOTA-Tyr(3)-
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuroendocrine Tumors
×
Palliative Care
×
Clear all
NCT01849523
2024-05-06
WIN
University Medical Center Groningen
Phase NA
Completed
20 enrolled